OTHERS MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" or "the Company") - MGRC COMPLETES 100TH HUMAN GENOME - General Announcement - Malaysia Data

4,798,267,200

1,903,738,752

497

616

4,274

3,732

280,646

General Announcement

17/11/2011

OTHERS MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" or "the Company") - MGRC COMPLETES 100TH HUMAN GENOME

MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD

Admission Sponsor	Kenanga Investment Bank Bhd
Sponsor	Same as above

Type	Announcement
Subject	OTHERS
Description	MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" or "the Company") - MGRC COMPLETES 100TH HUMAN GENOME
The following is a press release made by the Company for announcement to Bursa Malaysia Securities Berhad. *Kuala Lumpur, 17 November 2011* Malaysian Genomics Resource Centre Berhad (MGRC) today announced that it has successfully completed its 100th human genome from a diverse mix of Malaysian, European and Australian individuals. The results of the data generated from these genomes has helped in efforts to identify and compare highly represented patterns of common and clinically-relevant genetic variations within Malaysian and other populations, and to establish robust bioinformatics protocols for the reference-based analysis of genomic information. MGRC Chief Scientific Officer, Dr Stephen Rudd, explained, By reaching this milestone, MGRC has clearly demonstrated its capabilities in sequencing and analysing human genomes. It also further highlights the fact that genomics technologies and expertise are available in Malaysia for both the local and international life sciences community. The experience of analysing 100 human genomes has enabled MGRC to enhance its analytical pipelines and its proprietary Human Genome Browser. This puts the Company in the position of now being able to sequence and analyse a human genome in less than two weeks. These pipelines are already being used in the MyGenome Project to characterise patterns of human genetic variation in the Malaysian population. The MyGenome Project is a collaborative effort among Ministry of Science, Technology and Innovation (MOSTI), Malaysia Genome Institute (MGI), and MGRC. It was launched in November 2010 and it involves the deep sequencing and comprehensive bioinformatics analysis of 25 genomes from ethnic groups in Malaysia. About Malaysian Genomics Resource Centre Berhad Malaysian Genomics Resource Centre Berhad (MGRC) provides genome sequencing, bioinformatics analysis, and genetic screening services. The companys expertise is in the rapid sequencing and analysis of large volumes of genetic data. Since 2004, MGRC has developed extensive experience in the sequencing and analysis of human, animal, plant and microbial genomes, including large complex de novogenome assembly, for customers in Malaysia and overseas. Today MGRC operates one of the largest computational centres for genetic analysis in the region. - End of Press Release

Announcement Info

Company Name	MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD (ACE Market)
Stock Name	MGRC
Date Announced	17 Nov 2011
Category	General Announcement
Reference No	CS-111117-A2D36

Related Announcements for MGRC

Date	Title
07/11/2014	MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" or "the Company") - PROJECT AGREEMENT
04/11/2014	OTHERS MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" or "the Company") - PROJECT AGREEMENT
23/10/2014	OTHERS MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" or "the Company") - Proposed Renewal of Existing Shareholders' Mandate for Recurrent Related Party Transactions of a Revenue or Trading Nature
27/06/2014	MEMORANDUM OF UNDERSTANDING MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" or "the Company") - MEMORANDUM OF UNDERSTANDING BETWEEN FELDA WELLNESS CORPORATION SDN. BHD. AND THE COMPANY
17/02/2014	OTHERS MALAYSIAN GENOMICS RESOURCE BERHAD (“MGRCB” OR “THE COMPANY”) - ACQUISITION OF UP TO 30% EQUITY STAKE IN CLINIPATH (MALAYSIA) SDN BHD (“CM”) FOR A CASH CONSIDERATION OF AN AMOUNT EQUIVALENT APPROXIMATELY TO RM5,429,188.22 BY MPATH SDN. BHD., AN ENTITY JOINTLY CONTROLLED BY AJMAKS SDN BHD (“AJMAKS”) AND MGRCB (“ACQUISITION”)
19/12/2013	OTHERS MALAYSIAN GENOMICS RESOURCE BERHAD (“MGRCB” OR “THE COMPANY”) PROPOSED ACQUISITION OF UP TO 30% EQUITY STAKE IN CLINIPATH (MALAYSIA) SDN BHD (“CM”) FOR A CASH CONSIDERATION OF AN AMOUNT EQUIVALENT APPROXIMATELY TO RM5,429,188.22 BY MPATH SDN. BHD., AN ENTITY JOINTLY CONTROLLED BY AJMAKS SDN BHD (“AJMAKS”) AND MGRCB (“PROPOSED ACQUISITION”)
18/10/2013	MULTIPLE PROPOSALS MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" or "the Company") - Proposed Renewal of Existing Shareholders' Mandate for Recurrent Related Party Transactions of a Revenue or Trading Nature; - Proposed Increase in Authorised Share Capital; and - Proposed Amendments to the Memorandum of Association
05/12/2012	OTHERS MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD (“MGRC” or “Company”) – SUPPLEMENTAL AGREEMENT
03/12/2012	OTHERS MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD (“MGRC” or “Company”) – SUPPLEMENTAL AGREEMENT
03/12/2012	OTHERS MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD (“MGRC” OR “THE COMPANY”) - ADDITIONAL SUBSCRIPTION OF SHARES IN MPATH SDN. BHD., A SUBSIDIARY OF MGRC